The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.
Sickle Red Cell–Endothelium Interactions
Open accessAbstract
Periodic recurrence of painful vaso‐occlusive crisis is the defining feature of sickle cell disease. Among multiple pathologies associated with this disease, sickle red cell–endothelium interaction has been implicated as a potential initiating mechanism in vaso‐occlusive events. This review focuses on various interrelated mechanisms involved in human sickle red cell adhesion. We discuss in vitro and microcirculatory findings on sickle red cell adhesion, its potential role in vaso‐occlusion, and the current understanding of receptor‐ligand interactions involved in this pathological phenomenon. In addition, we discuss the contribution of other cellular interactions (leukocytes recruitment and leukocyte–red cell interaction) to vaso‐occlusion, as observed in transgenic sickle mouse models. Emphasis is given to recently discovered adhesion molecules that play a predominant role in mediating human sickle red cell adhesion. Finally, we analyze various therapeutic approaches for inhibiting sickle red cell adhesion by targeting adhesion molecules and also consider therapeutic strategies that target stimuli involved in endothelial activation and initiation of adhesion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Importantly, sickling-dependent damage of erythrocyte membranes also promotes exposure of adhesion molecules and binding motifs not normally expressed on erythrocytes, such as phosphatidyl serine (PS), basal cell adhesion molecule-1/Lutheran (B-CAM-1/Lu), integrin-associated protein (IAP), and intercellular-adhesion-molecule-4 (ICAM-4) (7, 9, 15).”
From Pathophysiology of Sickle Cell Disease (2019) · cites this paper as [15]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of the platelet ADP receptor targeted by antithrombotic drugs
Hollopeter, G., Jantzen, H., Vincent, D., Li, G., England, L. J., Ramakrishnan, V., Yang, R., Nurden, P., Nurden, A. T., Julius, D. J., et al. (2001) · Nature · doi:10.1038/35051599 · Cited by 1,421
Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
Reiter, C. D., Wang, X., Tanus-Santos, J. E., Hogg, N., Cannon, R. O., Schechter, A. N., & Gladwin, M. T. (2002) · Nature Medicine · doi:10.1038/nm1202-799 · Cited by 1,330
Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
Reiter, C. D., Wang, X., Tanus-Santos, J. E., et al. (2002) · Nature Medicine · doi:10.1038/nm799 · Cited by 1,097
Stuart, M. J., & Nagel, R. L. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17192-4 · Cited by 867
Circulating Activated Endothelial Cells in Sickle Cell Anemia
Solovey, A. N., Lin, Y., Browne, P., Choong, S., Wayner, E. A., & Hebbel, R. P. (1997) · New England Journal of Medicine · doi:10.1056/nejm199711273372203 · Cited by 626
Pfaff, M., Tangemann, K., Müller, B., Gurrath, M., Müller, G., Kessler, H., Timpl, R., & Engel, J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31981-6 · Cited by 535
Erythrocyte Adherence to Endothelium in Sickle-Cell Anemia
Hebbel, R. P., Boogaerts, M., Eaton, J. W., & Steinberg, M. H. (1980) · New England Journal of Medicine · doi:10.1056/nejm198005013021803 · Cited by 518
Primary role for adherent leukocytes in sickle cell vascular occlusion: A new paradigm
Turhan, A., Weiss, L. A., Mohandas, N., Coller, B. S., & Frenette, P. S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052522799 · Cited by 487
The Endothelial Biology of Sickle Cell Disease: Inflammation and a Chronic Vasculopathy
Hebbel, R. P., Osarogiagbon, R. U., & Kaul, D. K. (2004) · Microcirculation · doi:10.1080/10739680490278402 · Cited by 464
Self-citationSpontaneous oxygen radical generation by sickle erythrocytes.
Hebbel, R. P., Eaton, J. W., Balasingam, M., & Steinberg, M. H. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110724 · Cited by 444
Cited by
Sorted by citations
Pathophysiology of Sickle Cell Disease
Sundd, P., Gladwin, M. T., & Novelli, E. M. (2019) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012418-012838 · Cited by 813
Vaso-occlusion in sickle cell disease: pathophysiology and novel targeted therapies
Manwani, D., & Frenette, P. S. (2013) · Blood · doi:10.1182/blood-2013-05-498311 · Cited by 428
Zhang, D., Xu, C., Manwani, D., & Frenette, P. S. (2016) · Blood · doi:10.1182/blood-2015-09-618538 · Cited by 413
Barabino, G. A., Platt, M. O., & Kaul, D. K. (2010) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-070909-105339 · Cited by 311
Self-citationTsai, M., Kita, A., Leach, J., Rounsevell, R., Huang, J. N., Moake, J., Ware, R. E., Fletcher, D. A., & Lam, W. A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci58753 · Cited by 297
Role of red blood cells in haemostasis and thrombosis
Игоревич, Л. Р., & Weisel, J. W. (2016) · ISBT Science Series · doi:10.1111/voxs.12331 · Cited by 217
Shear-induced particle migration and margination in a cellular suspension
Zhao, H., Shaqfeh, E. S. G., & Narsimhan, V. (2012) · Physics of Fluids · doi:10.1063/1.3677935 · Cited by 189
Biomarkers in sickle cell disease
Rees, D. C., & Gibson, J. S. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.08961.x · Cited by 159
Sickle Cell Disease: Advances in Treatment
Gardner, R. V. (2018) · Ochsner Journal · doi:10.31486/toj.18.0076 · Cited by 136
Kinetics of sickle cell biorheology and implications for painful vasoocclusive crisis
Du, E., Diez-Silva, M., Kato, G. J., Dao, M., & Suresh, S. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1424111112 · Cited by 120
Daak, A. A., Ghebremeskel, K., Hassan, Z., Attallah, B., Azan, H. H., Elbashir, M. I., & Crawford, M. A. (2012) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.036319 · Cited by 120
Biomechanics and biorheology of red blood cells in sickle cell anemia
Li, X., Dao, M., Lykotrafitis, G., & Karniadakis, G. E. (2016) · Journal of Biomechanics · doi:10.1016/j.jbiomech.2016.11.022 · Cited by 119
Microvascular thrombosis: experimental and clinical implications
Bray, M. A., Sartain, S. E., Gollamudi, J., & Rumbaut, R. E. (2020) · Translational research · doi:10.1016/j.trsl.2020.05.006 · Cited by 126
Heterogeneous Red Blood Cell Adhesion and Deformability in Sickle Cell Disease
Alapan, Y., Little, J. A., & Gurkan, U. A. (2014) · Scientific Reports · doi:10.1038/srep07173 · Cited by 113
Chadebech, P., Habibi, A., Nzouakou, R., Bachir, D., Meunier‐Costes, N., Bonin, P., Rodet, M., Chami, B., Galactéros, F., Bierling, P., et al. (2009) · Transfusion · doi:10.1111/j.1537-2995.2009.02199.x · Cited by 113
Advances in the Treatment of Sickle Cell Disease
Kapoor, S., Little, J. A., & Pecker, L. H. (2018) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2018.08.001 · Cited by 110
Advances in understanding the pathogenesis of cerebrovascular vasculopathy in sickle cell anaemia
Connes, P., Verlhac, S., & Bernaudin, F. (2013) · British Journal of Haematology · doi:10.1111/bjh.12300 · Cited by 102
Vaso-occlusion in sickle cell disease: pathophysiology and novel targeted therapies
Manwani, D. G., & Frenette, P. S. (2013) · Hematology · doi:10.1182/asheducation-2013.1.362 · Cited by 94
Tebbi, C. K. (2022) · Hemato · doi:10.3390/hemato3020024 · Cited by 110
Alapan, Y., Kim, C., Adhikari, A., Gray, K. E., Gürkan-Çavusoglu, E., Little, J. A., & Gurkan, U. A. (2016) · Translational research · doi:10.1016/j.trsl.2016.03.008 · Cited by 77
Leonard, A. K., Bonifacino, A. C., Dominical, V. M., Luo, M., Haro‐Mora, J. J., Demirci, S., Uchida, N., Pierciey, F. J., & Tisdale, J. F. (2019) · British Journal of Haematology · doi:10.1111/bjh.15902 · Cited by 76
Dynamic deformability of sickle red blood cells in microphysiological flow
Alapan, Y., Matsuyama, Y., Little, J. A., & Gurkan, U. A. (2016) · TECHNOLOGY · doi:10.1142/s2339547816400045 · Cited by 76
Hemoglobin disorders and endothelial cell interactions
Conran, N., & Costa, F. F. (2009) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2009.06.024 · Cited by 75
Simultaneous polymerization and adhesion under hypoxia in sickle cell disease
Papageorgiou, D. P., Abidi, S. Z., Chang, H.-Y., Li, X., Kato, G. J., Karniadakis, G. E., Suresh, S., & Dao, M. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1807405115 · Cited by 74
Ischemia-Reperfusion Injury in Sickle Cell Disease
Ansari, J., & Gavins, F. N. E. (2019) · American Journal Of Pathology · doi:10.1016/j.ajpath.2018.12.012 · Cited by 81
Clinical biomarkers in sickle cell disease
Damanhouri, G. A., Jarullah, J. S., Marouf, S., Hindawi, S., Mushtaq, G., & Kamal, M. A. (2014) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2014.09.005 · Cited by 72
AAAPT Diagnostic Criteria for Acute Sickle Cell Disease Pain
Field, J. J., Ballas, S. K., Campbell, C. M., Crosby, L. E., Dampier, C., Darbari, D. S., McClish, D. K., Smith, W. R., & Zempsky, W. T. (2018) · Journal of Pain · doi:10.1016/j.jpain.2018.12.003 · Cited by 73
Kucukal, E., Man, Y., Hill, A., Liu, S., Bode, A., An, R., Kadambi, J. R., Little, J. A., & Gurkan, U. A. (2020) · American Journal of Hematology · doi:10.1002/ajh.25933 · Cited by 71
Role of Endothelial Cells in Acute and Chronic Thrombosis
Bochenek, M. L., & Schäfer, K. (2019) · Hämostaseologie · doi:10.1055/s-0038-1675614 · Cited by 72
Phase 1 Study of the E-Selectin Inhibitor GMI 1070 in Patients with Sickle Cell Anemia
Wun, T., Styles, L., DeCastro, L., Telen, M. J., Kuypers, F., Cheung, A., Kramer, W., Flanner, H., Rhee, S., Magnani, J. L., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101301 · Cited by 69
Henry, E. R., Cellmer, T., Dunkelberger, E. B., Metaferia, B., Hofrichter, J., Li, Q., Ostrowski, D., Ghirlando, R., Louis, J. M., Moutereau, S., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1922004117 · Cited by 65
Emerging point-of-care technologies for sickle cell disease screening and monitoring
Alapan, Y., Fraiwan, A., Kucukal, E., Hasan, M. N., Ung, R., Kim, M., Odame, I., Little, J. A., & Gurkan, U. A. (2016) · Expert Review of Medical Devices · doi:10.1080/17434440.2016.1254038 · Cited by 66
Review/overview of pain in sickle cell disease
Ballas, S. K., & Darbari, D. S. (2020) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2020.102327 · Cited by 60
The delay time in sickle cell disease after 40 years: A paradigm assessed
Ferrone, F. A. (2015) · American Journal of Hematology · doi:10.1002/ajh.23958 · Cited by 56
PERIOPERATIVE MANAGEMENT OF SICKLE CELL DISEASE: A NARRATIVE REVIEW
Adjepong, K., Otegbeye, F., & Adjepong, Y. (2018) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2018.032 · Cited by 56
Daak, A. A., Elderdery, A. Y., Elbashir, L. M., Mariniello, K., Mills, J. J., Scarlett, G. P., Elbashir, M. I., & Ghebremeskel, K. (2015) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2015.03.014 · Cited by 54
Hatzipantelis, E., Pana, Z. D., Gombakis, N., Ταπάρκου, Ά., Tzimouli, V., Kleta, D., Zafeiriou, D., Garipidou, V., Kanakoudi, F. G., & Athanassiou, M. (2013) · International Journal of Hematology · doi:10.1007/s12185-013-1392-y · Cited by 54
Does physical activity increase or decrease the risk of sickle cell disease complications?
Martin, C., Pialoux, V., Faës, C., Charrin, E., Skinner, S. C., & Connes, P. (2015) · British Journal of Sports Medicine · doi:10.1136/bjsports-2015-095317 · Cited by 55
Kucukal, E., Ilich, A., Key, N. S., Little, J. A., & Gurkan, U. A. (2018) · American Journal of Hematology · doi:10.1002/ajh.25159 · Cited by 54
THE EVOLVING PHARMACOTHERAPEUTIC LANDSCAPE FOR THE TREATMENT OF SICKLE CELL DISEASE
Ballas, S. K. (2020) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2020.010 · Cited by 52
Koehl, B., Nivoit, P., Nemer, W. E., Lenoir, O., Hermand, P., Pereira, C., Brousse, V. A. M., Guyonnet, L., Ghinatti, G., Benkerrou, M., et al. (2017) · Haematologica · doi:10.3324/haematol.2016.156869 · Cited by 51
Man, Y., Goreke, U., Kucukal, E., Hill, A., An, R., Liu, S., Bode, A., Solis-Fuentes, A., Nayak, L. V., Little, J. A., et al. (2020) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2020.102424 · Cited by 46
The relation of C-reactive protein to vasoocclusive crisis in children with sickle cell disease
Mohammed, F. A.-K., Mahdi, N., Sater, M. S., Al‐Ola, K., & Almawi, W. Y. (2010) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2010.08.003 · Cited by 45
Red cell adhesion in human diseases
Colin, Y., Kim, C. L. V., & Nemer, W. E. (2014) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000036 · Cited by 41
Cellular-level near-wall unsteadiness of high-hematocrit erythrocyte flow using confocal μPIV
Patrick, M. J., Chen, C., Frakes, D. H., Dur, O., & Pekkan, K. (2010) · Experiments in Fluids · doi:10.1007/s00348-010-0943-8 · Cited by 40
Foell, J. L., Pfirstinger, B., Rehe, K., Wolff, D., Holler, E., & Corbacioglu, S. (2017) · Bone Marrow Transplantation · doi:10.1038/bmt.2017.49 · Cited by 38
Bennewitz, M. F., Watkins, S. C., & Sundd, P. (2014) · IntraVital · doi:10.4161/intv.29748 · Cited by 37
Daak, A. A., Dampier, C., Fuh, B., Kanter, J., Alvarez, O. A., Black, L. V., McNaull, M. A., Callaghan, M. U., George, A., Neumayr, L., et al. (2018) · Blood Advances · doi:10.1182/bloodadvances.2018021444 · Cited by 37
Aich, A., Jones, M. K., & Gupta, K. (2019) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000491 · Cited by 37
Eleutério, R. M. N., Nascimento, F. O., de Araújo, T. G., de Castro, M. F., Filho, T. P. D. A., Filho, P. A. M., Eleutério, J., Elias, D. B. D., & Lemes, R. P. G. (2019) · Advances in Hematology · doi:10.1155/2019/4397150 · Cited by 38
Hermand, P., Azouzi, S., Gautier, E., Guillonneau, F., Bondet, V., Duffy, D., Dechavanne, S., Tharaux, P., Mayeux, P., Kim, C. L. V., et al. (2020) · Haematologica · doi:10.3324/haematol.2019.238295 · Cited by 34
Quantifying Shear-Induced Deformation and Detachment of Individual Adherent Sickle Red Blood Cells
Deng, Y., Papageorgiou, D. P., Chang, H.-Y., Abidi, S. Z., Li, X., Dao, M., & Karniadakis, G. E. (2018) · Biophysical Journal · doi:10.1016/j.bpj.2018.12.008 · Cited by 32
Understanding apoptosis in sickle cell anemia patients: Mechanisms and implications
Obeagu, E. I., Ubosi, N. I., Obeagu, G. U., Egba, S. I., & Bluth, M. H. (2024) · Medicine · doi:10.1097/md.0000000000036898 · Cited by 27
Microarchitectural and mechanical characterization of the sickle bone
Green, M., Akinsami, I., Lin, A., Banton, S., Ghosh, S., Chen, B., Platt, M. O., Osunkwo, I., Ofori-Acquah, S. F., Guldberg, R. E., et al. (2015) · Journal of the mechanical behavior of biomedical materials/Journal of mechanical behavior of biomedical materials · doi:10.1016/j.jmbbm.2015.04.019 · Cited by 27
Self-citationHypoxia/reoxygenation stress increases markers of vaso-occlusive crisis in sickle SAD mice
Aufradet, É., DeSouza, G., Bourgeaux, V., Bessaad, A., Campion, Y., Canet‐Soulas, E., Pialoux, V., Chirico, E. N., Chevrier, A., Godfrin, Y., et al. (2013) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-131735 · Cited by 27
Sickle cell disease: Hemostatic and inflammatory changes, and their interrelation
Toledo, S. L. D. O., Guedes, J. V. M., Alpoim, P. N., Rios, D. R. A., & Pinheiro, M. D. B. (2019) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.02.026 · Cited by 25
Research in Sickle Cell Disease: From Bedside to Bench to Bedside
Cisneros, G. S., & Thein, S. L. (2021) · HemaSphere · doi:10.1097/hs9.0000000000000584 · Cited by 25
State of the Art Management of Acute Vaso-occlusive Pain in Sickle Cell Disease
Puri, L., Nottage, K. A., Hankins, J. S., & Anghelescu, D. L. (2017) · Pediatric Drugs · doi:10.1007/s40272-017-0263-z · Cited by 28
Emerging drugs for sickle cell anemia
Singh, P. C., & Ballas, S. K. (2014) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2015.985587 · Cited by 24
Airway inflammation in sickle cell disease—A translational perspective
De, A., Manwani, D. G., & Rastogi, D. (2018) · Pediatric Pulmonology · doi:10.1002/ppul.23932 · Cited by 24
Terman, D. S., Viglianti, B. L., Zennadi, R., Fels, D. R., Boruta, R. J., Yuan, H., Dreher, M. R., Grant, G. A., Rabbani, Z. N., Moon, E., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0052543 · Cited by 23
Trauma-Hemorrhagic Shock Induces a CD36-Dependent RBC Endothelial-Adhesive Phenotype
Deitch, E. A., Condon, M. R., Feketeova, E., Machiedo, G. W., Mason, L., Vinluan, G. M., Alli, V. V., Neal, M. D., Tomaio, J. N., Fishman, J. E., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0000000000000119 · Cited by 23
Lu, X., Galarneau, M., Higgins, J. M., & Wood, D. K. (2017) · Microcirculation · doi:10.1111/micc.12357 · Cited by 23
Meier, E. R., Fasano, R. M., Estrada, M., He, J., Luban, N. L. C., & McCarter, R. (2015) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2015.10.031 · Cited by 22
Oxidative stress activates red cell adhesion to laminin in sickle cell disease
Lizarralde-Iragorri, M. A., Lefevre, S. D., Cochet, S., Hoss, S. E., Brousse, V. A. M., Filipe, A., Dussiot, M., Azouzi, S., Kim, C. L. V., Rodrigues‐Lima, F., et al. (2020) · Haematologica · doi:10.3324/haematol.2020.261586 · Cited by 22
Neutrophils as drivers of vascular injury in sickle cell disease
Torres, L. S., & Hidalgo, A. (2022) · Immunological Reviews · doi:10.1111/imr.13146 · Cited by 22
Efficacy of homologous inositol hexaphosphate‐loaded red blood cells in sickle transgenic mice
Bourgeaux, V., Aufradet, É., Campion, Y., Souza, G. D., Horand, F., Bessaad, A., Chevrier, A., Canet‐Soulas, E., Godfrin, Y., & Martin, C. (2012) · British Journal of Haematology · doi:10.1111/j.1365-2141.2012.09077.x · Cited by 20
Alkindi, S. S. A., Al-Ghadani, A. R., Al-Zeheimi, S. R., Alkindi, S. Y., Fawaz, N., Ballas, S. K., & Pathare, A. V. (2021) · Journal of International Medical Research · doi:10.1177/03000605211055385 · Cited by 18
Neutrophil microdomains: linking heterocellular interactions with vascular injury
Scheiermann, C., Kunisaki, Y., Jang, J.-E., & Frenette, P. S. (2009) · Current Opinion in Hematology · doi:10.1097/moh.0b013e328333d2a3 · Cited by 18
Recent advances in “sickle and niche” research - Tribute to Dr. Paul S Frenette -
Torres, L. S., Asada, N., Weiss, M. J., Trumpp, A., Suda, T., Scadden, D. T., & Ito, K. (2022) · Stem Cell Reports · doi:10.1016/j.stemcr.2022.06.004 · Cited by 19
Abdul-Hussein, H. K., Al-Mamoori, H. S., & Hassan, M. K. (2021) · Cytokine · doi:10.1016/j.cyto.2021.155534 · Cited by 15
MTHFR Polymorphic Variant C677T Is Associated to Vascular Complications in Sickle-Cell Disease
Hatzlhofer, B. L. D., Bezerra, M. A. C., Santos, M. N. N., de Albuquerque, D. M., Freitas, E. M., Costa, F. F., Araujo, A. S., & Muniz, M. T. C. (2012) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2011.0361 · Cited by 15
Riley, T. R., & Riley, T. T. (2019) · Journal of Blood Medicine · doi:10.2147/jbm.s191423 · Cited by 15
Interleukin-1 receptor inhibition reduces stroke size in a murine model of sickle cell disease
Venugopal, J., Wang, J., Mawri, J., Guo, C., & Eitzman, D. T. (2020) · Haematologica · doi:10.3324/haematol.2020.252395 · Cited by 15
Mean platelet volume can predict cerebrovascular events in patients with Sickle Cell Anemia
Çelik, T., Ünal, Ş., Ekıncı, O., Özer, C., İlhan, G., Oktay, G., & Arıca, V. (2014) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.311.4104 · Cited by 14
Erukainure, O. L., Ajiboye, J., Abbah, U., Asieba, G. O., Mamuru, S. A., Zaruwa, M. Z., Manhas, N., Singh, P., & Islam, M. (2017) · Human & Experimental Toxicology · doi:10.1177/0960327117712385 · Cited by 14
Sickle Cell Disease Pathophysiology and Related Molecular and Biophysical Biomarkers
Saah, E. N., Fadaei, P., Gurkan, U. A., & Sheehan, V. (2022) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2022.06.005 · Cited by 14
Opene, M., Kurantsin‐Mills, J., Husain, S., & Ibe, B. O. (2014) · Pulmonary Circulation · doi:10.1086/677363 · Cited by 13
Najjar, S. A., Adam, S. S., Ahmed, N., & Qari, M. (2016) · Annals of Hematology · doi:10.1007/s00277-016-2823-7 · Cited by 14
Clinical Implications of Single-Cell Microfluidic Devices for Hematological Disorders
Hansen, C. E., & Lam, W. A. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.7b01013 · Cited by 13
Silva, M., & Faustino, P. (2023) · Antioxidants · doi:10.3390/antiox12111977 · Cited by 17
Plasma Ischemia Modified Albumin Levels and Dynamic Thiol / Disulfide Balance in Sickle Cell Disease
Özcan, O., Erdal, H., İlhan, G., Demir, D., Gürpınar, A. B., Neşeli̇oğlu, S., & Erel, Ö. (2018) · Turkish Journal of Hematology · doi:10.4274/tjh.2018.0119 · Cited by 12
Al‐Subaie, A. M., Fawaz, N., Mahdi, N., Al‐Absi, I. K., Al‐Ola, K., Ameen, G., & Almawi, W. Y. (2009) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2009.01339.x · Cited by 12
Sahu, T. A., Pande, B., Verma, H. K., Bhaskar, L. V., Sinha, M., Sinha, R., & Rao, P. V. (2023) · Thalassemia Reports · doi:10.3390/thalassrep13030019 · Cited by 11
Pathobiology of Sickle Cell Disease
Hebbel, R. P., & Vercellotti, G. M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35762-3.00041-x · Cited by 11
Thrombo-Inflammation in COVID-19 and Sickle Cell Disease: Two Faces of the Same Coin
Chiang, K. C., Gupta, A., Sundd, P., & Krishnamurti, L. (2023) · Biomedicines · doi:10.3390/biomedicines11020338 · Cited by 10
Ranque, B., Diaw, M., Dembélé, A. K., Lapouméroulie, C., Offredo, L., Tessougué, O., Gueye, S. M., Diallo, D. A., Diop, S., Colin, Y., et al. (2023) · British Journal of Haematology · doi:10.1111/bjh.19006 · Cited by 11
Sawadogo, D., Tolo-Dilkébié, A., Mahawa, S., Aguéhoundé, N., Kassi, H., & Latte, T. (2014) · Advances in Hematology · doi:10.1155/2014/273860 · Cited by 11
Hyperbaric oxygen therapy for vaso-occlusive crises in nine patients with sickle-cell disease.
Stirnemann, J., Letellier, E., Aras, N., Borne, M., Brinquin, L., & Fain, O. (2012) · PubMed · Cited by 10
Adhesion molecules and cerebral microvascular hemodynamic abnormalities in sickle cell disease
Rached, N. A., Gbotosho, O. T., Archer, D. R., Jones, J. A., Sterling, M. S., & Hyacinth, H. I. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.976063 · Cited by 10
Role of blood viscosity in the microcirculation
Jung, F., & RAMPLING, M. W. (2016) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-168108 · Cited by 10
Identification of Aptamers That Bind to Sickle Hemoglobin and Inhibit Its Polymerization
Purvis, S. H., Keefer, J. R., Fortenberry, Y. M., Barron‐Casella, E. A., & Casella, J. F. (2017) · Nucleic Acid Therapeutics · doi:10.1089/nat.2016.0646 · Cited by 10
Chamouine, A., Saandi, T., Muszlak, M., Larmaraud, J., Lambrecht, L., Poisson, J. P., Balicchi, J., Pissard, S., & Elenga, N. (2020) · BMC Pediatrics · doi:10.1186/s12887-020-02187-6 · Cited by 10
Niesor, E. J., Benghozi, R., Amouyel, P., Ferdinand, K. C., & Schwartz, G. G. (2015) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-015-6626-1 · Cited by 10
Targeting PIEZO1 ‐ TMEM16F Coupling to Mitigate Sickle Cell Disease Complications
Liang, P., Wan, Y., Shan, K. Z., Chou, R., Zhang, Y., Delahunty, M. D., Khandelwal, S., Francis, S., Arepally, G. M., Telen, M. J., et al. (2025) · American Journal of Hematology · doi:10.1002/ajh.70086 · Cited by 9
Lu, M., Kanne, C. K., Reddington, R. C., Lezzar, D. L., Sheehan, V., & Shevkoplyas, S. S. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.633080 · Cited by 9
Pain Control for Sickle Cell Crisis, a Novel Approach? A Retrospective Study
Rollé, A., Vidal, E., Laguette, P., Garnier, Y., Delta, D., Martino, F., Portecop, P., Etienne‐Julan, M., Piednoir, P., JONG, A. D., et al. (2023) · Medicina · doi:10.3390/medicina59122196 · Cited by 9
Enfermedades hematológicas: desde dentro del corazón
Xu, W., Wang, T. Y., & Becker, R. C. (2011) · Revista Española de Cardiología · doi:10.1016/j.recesp.2011.02.018 · Cited by 9
Inflammation and Sickle Cell Anemia
Almeida, C. B., Kato, G. J., & Conran, N. (2016) · Springer eBooks · doi:10.1007/978-3-319-06713-1_8 · Cited by 9
Nugent, W. H., Jubin, R., Buontempo, P. J., Kazo, F., & Song, B. K. (2019) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2018.1543197 · Cited by 9
Metadata
- Authors
- KAUL, D. K., FINNEGAN, E., & BARABINO, G. A.
- Affiliations
- Albert Einstein College of Medicine (US)
- Georgia Institute of Technology (US)
- Corresponding author
- KAUL, DHANANJAY K.
- ORCID
- BARABINO, GILDA A.
- Venue
- Microcirculation
- Publisher
- Wiley
- Published
- 2009-01
- Volume
- 16
- Issue
- 1
- Pages
- 97-111
- ISSN
- 1073-9688 (ISSN-L)
- 1549-8719
- PMC
- PMC3059190
- OpenAlex
- W2067770510
- Cited by
- 208
- References
- 85
- Citations by year
- 2026: 5 · 2025: 11 · 2024: 6 · 2023: 12 · 2022: 14 · 2021: 9 · 2020: 20 · 2019: 15 · 2018: 15 · 2017: 17 · 2016: 19 · 2015: 13 · 2014: 16 · 2013: 12 · 2012: 6
- FWCI
- 0.63
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Microcirculation (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- U.S. Public Health Service (U54 070994)
- National Heart, Lung, and Blood Institute (HL071631, R01HL070047, K25HL071631)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Health Sciences › Medicine › Hematology › Blood properties and coagulation
- Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
- Keywords
- sickle cell disease, endothelium, vascular occlusion, ligand-receptor interactions, adhesion molecules, leukocyte recruitment, endothelial activation, anti-adhesion therapy
- MeSH terms
- Anemia, Sickle Cell, Animals, Cell Adhesion, Cell Communication, Endothelium, Vascular, Erythrocytes, Abnormal, Humans, Leukocytes, Mice, Transgenic, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review